Related Experiment Video

Updated: Aug 18, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Role of epidermal growth factor receptor signaling in RAS-driven melanoma

Nabeel Bardeesy1, Minjung Kim, Jin Xu

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. nelbardeesy@partners.org

Molecular and Cellular Biology
|May 5, 2005
PubMed

Insights

Identifying key genes in tumor maintenance is crucial for cancer drug development. This study found that a specific RAS signaling loop is essential for melanoma growth, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Identifying essential genetic elements for tumor maintenance is critical for developing effective antioncologic agents.
  • Previous research highlighted the essential role of H-RAS(V12G) in melanoma maintenance using an inducible transgenic model.

Purpose of the Study:

  • To define the molecular basis of RAS-dependent tumor maintenance.
  • To determine the H-RAS(V12G)-directed transcriptional program and validate potential signaling surrogates.

Main Methods:

  • Utilized an inducible transgenic melanoma model to study H-RAS(V12G) function.
  • Analyzed the transcriptional program regulated by H-RAS(V12G).
  • Performed genetic complementation and interference studies to validate signaling pathways.

Main Results:

  • H-RAS(V12G) expression extinction led to decreased expression of proliferative, antiapoptotic, and angiogenic genes.
  • Tumor regression was observed, characterized by cell cycle arrest, apoptosis, and endothelial cell death.
  • A prominent RAS-dependent regulation of the epidermal growth factor (EGF) family was identified, forming an EGF receptor signaling loop.
  • This EGF receptor signaling loop was demonstrated to be essential for H-RAS(V12G)-driven tumorigenesis.

Conclusions:

  • The study identified a critical RAS-dependent EGF receptor signaling loop essential for melanoma maintenance.
  • This inducible tumor model allows for the identification and validation of alternative therapeutic intervention points.
  • Therapeutic strategies can be developed targeting this signaling loop without directly neutralizing the primary genetic lesion (H-RAS).

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: